Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Celltrion issued a correction disclosure regarding its Investor Relations (IR) presentation held on November 27, 2024, to update the event proceeding details (Korean-English interpretation provided for both presentation and Q&A session).
📊 Key Disclosure Content & Financial Highlights
- Overview
- Company: Celltrion, Inc. (Stock Code: 068270)
- Disclosure Type: (Correction) Investor Relations (IR) Presentation
- Correction Filing Date: November 27, 2024 (Original Filing Date: November 26, 2024)
- Reason for Correction: Text correction due to changes in event proceeding details
- Key Correction Details
- Other Important Matters Related to Investment Decisions:
- Before Correction: As this is an overseas IR event, presentation material will be delivered in English, and Korean-English interpretation will be provided during the Q&A session.
- After Correction: As this is an overseas IR event, Korean-English interpretation will be provided for both the presentation and the Q&A session.
- Investor Relations (IR) Event Details
- Date & Time: November 27, 2024, at 16:00 (KST)
- Method & Venue: Online (Live streaming of Hong Kong IR presentation via Celltrion YouTube channel)
- Target Audience: Shareholders and domestic/international investors
- Purpose: Enhance investor understanding of key management issues (Hosting Hong Kong IR Event)
- Key Topics: Presentation and Q&A on major business issues including biosimilar outlook, new portfolio expansion, new drug development, and CDMO business
- IR Material Posting: Scheduled to be posted on Celltrion’s official website prior to the live broadcast on November 27, 2024
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of IR Presentation Materials and Business Updates
This disclosure serves as official notification regarding text corrections concerning Korean-English interpretation for Celltrion’s Hong Kong IR event. Tracking the IR presentation materials posted on Celltrion’s official website and key business disclosures (biosimilar outlook, CDMO business progress) presented during the live stream is important for staying updated on strategic execution. Relevant updates can be confirmed on the official company website and subsequent disclosures.
📢 Disclaimer & Source Notice
Source: This content was structured and generated based on official disclosure data from the Financial Supervisory Service’s DART system.
Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
